These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 2645707

  • 1. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 2. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J, Marcén R, Orofino L, Quereda C, Mampaso F, Liaño F, Ortuño J.
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 4. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 5. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
    Sumrani N, Delaney V, Ding ZK, Butt K, Hong J.
    Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
    [Abstract] [Full Text] [Related]

  • 7. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 8. Long-term beneficial effects of azathioprine addition to ongoing cyclosporine-prednisone protocol in renal transplantation.
    Pascual J, Marcén R, Orofino L, Quereda C, Teruel JL, Mampaso F, Liaño F, Villafruela JJ, Ortuño J.
    Transpl Int; 1992 Nov; 5 Suppl 1():S107-9. PubMed ID: 14621748
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L, Ding T, Wang XX, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
    Kupin WL, Venkat KK, Norris C, Florence-Green D, Dienst S, Oh HK, Feldkamp C, Levin NW.
    Transplantation; 1987 Feb 27; 43(2):214-8. PubMed ID: 3544378
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
    MacPhee IA, Bradley JA, Briggs JD, Junor BJ, MacPherson SG, McMillan MA, Rodger RS, Watson MA.
    Transplantation; 1998 Nov 15; 66(9):1186-92. PubMed ID: 9825816
    [Abstract] [Full Text] [Related]

  • 16. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
    Henny FC, Kootte AM, Van Bockel JH, Baldwin WM, Hermans J, Bos B, van Es LA, Paul LC.
    Nephrol Dial Transplant; 1986 Dec 15; 1(1):44-9. PubMed ID: 3110662
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
    Gonwa TA, Nghiem DD, Schulak JA, Corry RJ.
    Transplantation; 1987 Feb 15; 43(2):225-8. PubMed ID: 3544380
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.